文献速递心血管USMRCT

右心房起搏对心脏再同步化治疗中左心房功能及临床结局的不利影响

The Detrimental Effect of RA Pacing on LA Function and Clinical Outcome in Cardiac Resynchronization Therapy.
PubMed 文献 · JACC Cardiovasc Imaging · 2019-07-17

本研究评估右心房起搏对左心房生理及临床结局的影响。影像队列显示高右心房起搏负荷患者左心房容积、排空分数及应变改善更差,并出现显著心内失同步;结局队列显示高右心房起搏负荷与左室逆重构减少及新发或复发房颤风险增加相关,心衰再入院更常见。作者认为减少右心房起搏负荷的策略可能有必要。

要点

  • 高右心房起搏负荷(>50%)患者左心房最大/最小容积及总排空分数改善更差,应变指标恶化。
  • 高右心房起搏负荷诱导显著心内失同步,最大对壁延迟97±17 ms vs 44±13 ms(P=0.022)。
  • 高右心房起搏负荷与左室逆重构减少及新发/复发房颤风险增加(41% vs 22%)相关。

核心结论

  • 心脏再同步化治疗患者中右心房起搏对左心房形态、功能和同步性产生负面影响,并与左室逆重构减少、新发或复发房颤及心衰再入院风险增加相关,减少右心房起搏负荷的策略可能有必要。

研究设计与样本

  • 前瞻性影像队列纳入36例窦性心律且有心脏再同步化治疗指南适应症的心衰患者(68±11岁),评估右心房起搏对左心房功能、形态及同步性的影响;回顾性结局队列纳入569例连续接受心脏再同步化治疗植入的心衰患者,分析右心房起搏与多种结局终点的关系。两个队列均以心房起搏比例高于或低于50%定义高或低心房起搏负荷。

关键影像表现/征象

  • 心脏再同步化治疗6个月后,高右心房起搏负荷患者左心房最大和最小容积及总排空分数改善更少(p<0.05)。
  • 低右心房起搏负荷患者峰值心房纵向应变及储备和助推应变率在心脏再同步化治疗后改善,高负荷患者则恶化(p均<0.05),而导管应变率无此差异。
  • 高右心房起搏负荷诱导显著心内失同步,最大对壁延迟为97±17 ms,低负荷组为44±13 ms(p=0.022)。

诊断标准与关键数值

  • 高与低心房起搏负荷定义为心房起搏比例高于或低于50%,两个队列均采用此阈值。
  • 影像队列中峰值心房纵向应变及储备和助推应变率在高负荷组恶化、低负荷组改善(p<0.05),导管应变率无显著差异。
  • 结局队列经协变量调整后,高右心房起搏负荷与左室逆重构减少相关(β=8.738;95%CI:3.101至14.374;p=0.002)。
  • 高右心房起搏负荷组新发或复发房颤发生率为41%,低负荷组为22%(中位随访31个月,范围22至44个月;p<0.001)。

临床应用与阅片要点

  • 阅片及随访心脏再同步化治疗患者时,应关注右心房起搏负荷比例,高负荷(>50%)提示左心房功能及同步性改善可能较差。
  • 高右心房起搏负荷与左室逆重构减少、新发或复发房颤风险增加及心衰再入院更常见相关,报告时可结合起搏参数提示临床。
  • 作者认为减少右心房起搏负荷的策略可能有必要。

局限性

  • 影像队列样本量为36例。
  • 结局队列为回顾性分析。
  • 作者结论中提出减少右心房起搏负荷的策略可能有必要,尚需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study assessed the impact of right-atrial (RA) pacing on left-atrial (LA) physiology and clinical outcome.

BACKGROUND: Data for the effects of RA pacing on LA synchronicity, function, and structure after cardiac resynchronization therapy (CRT) are scarce.

METHODS: The effect of RA pacing on LA function, morphology, and synchronicity was assessed in a prospective imaging cohort of heart failure (HF) patients in sinus rhythm with a guideline-based indication for CRT. Additionally, in a retrospective outcome cohort of consecutive HF patients undergoing CRT implantation, the relationship to RA pacing was assessed using various outcome endpoints. High versus low atrial pacing burden was defined as atrial pacing above or below 50% in both cohorts.

RESULTS: A total of 36 patients were included in the imaging cohort (68 ± 11 years of age). Six months after CRT, patients with high RA pacing burden showed less improvement in LA maximum and minimum volumes and total emptying fraction (p < 0.05). Peak atrial longitudinal strain and reservoir and booster strain rates but not conduit strain rate improved after CRT in patients with low RA pacing burden but worsened in patients with high RA pacing burden (p < 0.05 for all). A high RA pacing burden induced significant intra-atrial dyssynchrony (maximum opposing wall delay: 44 ± 13 ms vs. 97 ± 17 ms, respectively; p = 0.022). A total of 569 patients were included in the outcome cohort. After covariate adjustments were made, a high RA pacing burden was associated with reduced LV reverse remodeling (β = 8.738; 95% confidence interval [CI]: 3.101 to 14.374; p = 0.002) and new-onset or recurrent atrial fibrillation (41% vs. 22%, respectively, at a median of 31 months [range 22 to 44 months follow-up]; p < 0.001). There were no differences in time to first HF hospitalization or all-cause mortality (p = 0.185) after covariate adjustment. However, in a recurrent event analysis, HF readmissions were more common in patients exposed to a high RA pacing burden (p = 0.003).

CONCLUSIONS: RA pacing in CRT patients negatively influences LA morphology, function, and synchronicity, which is associated with worse clinical outcome, including diminished LV reverse remodeling, increased risk for new-onset or recurrent AF and heart failure readmission. Strategies reducing RA pacing burden may be warranted.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Martens P, Deferm S, Bertrand PB, et al. The Detrimental Effect of RA Pacing on LA Function and Clinical Outcome in Cardiac Resynchronization Therapy. JACC Cardiovasc Imaging. 2019. PMID: 31326478. doi:10.1016/j.jcmg.2019.04.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。